Skip to content

Common Stock at other companies

ALN
Alnylam PharmaceuticalsALNY
250M0.0%
Septerna, Inc. logo
Septerna, Inc.SEPN
$45K+2.3%
Regenxbio logo
RegenxbioRGNX
$5K0.0%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$91K+4.6%
Opko Health logo
Opko HealthOPK
$7.85M+11.9%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
15.8B0.0%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's common stock?
Tectonic Therapeutics (TECX) reported common stock of $2K in Q1 2026.
How has Tectonic Therapeutics's common stock changed year-over-year?
Tectonic Therapeutics's common stock decreased by 100.0% year-over-year, from $150M to $2K.
What is the long-term trend for Tectonic Therapeutics's common stock?
Over 5 years (2020 to 2025), Tectonic Therapeutics's common stock has grown at a -12.9% compound annual growth rate (CAGR), from $4K to $2K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).